On the readiness of physicians for pharmacogenomics testing: an empirical assessment N Amara, J Blouin-Bougie, D Bouthillier, J Simard The pharmacogenomics journal 18 (2), 308-318, 2018 | 32 | 2018 |
Medical genetic counseling for breast cancer in primary care: a synthesis of major determinants of physicians' practices in primary care settings J Jbilou, N Halilem, J Blouin-Bougie, N Amara, R Landry, J Simard Public health genomics 17 (4), 190-208, 2014 | 27 | 2014 |
Breast cancer risk estimation and personal insurance: a qualitative study presenting perspectives from canadian patients and decision makers G Dalpé, I Ngueng Feze, S Salman, Y Joly, J Hagan, E Lévesque, ... Frontiers in Genetics 8, 128, 2017 | 25 | 2017 |
Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among … J Blouin-Bougie, N Amara, K Bouchard, J Simard, M Dorval BMJ open 8 (2), e016662, 2018 | 12 | 2018 |
Toward a population-based breast cancer risk stratification approach? The needs and concerns of healthcare providers J Blouin-Bougie, N Amara, J Simard Journal of Personalized Medicine 11 (6), 540, 2021 | 11 | 2021 |
The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes N Amara, J Blouin-Bougie, J Jbilou, N Halilem, J Simard, R Landry Familial Cancer 15, 1-17, 2016 | 11 | 2016 |